*Announces acquisition of manufacturing facility. *Says in total consideration for anc, NuVasive will pay approximately $4.5. *Says no debt will be assumed in the deal.
*RBC raises target price to $23 from $21; rating sector perform. Reuters Station users, click. 1568. Reuters Station users, click. 4899.
*Canaccord Genuity raises target price to $26 from $25; rating buy. Reuters Station users, click. 1568. Reuters Station users, click. 4899.
March 27- A U.S. government watchdog has issued a warning about the risk for fraud when doctors buy an ownership interest in a medical device distributor and then share in its profits from sales to hospitals.